Trans Tech Pharma

We are a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of human therapeutics to fill unmet medical needs. Our mission is to utilize our innovative technology to rapidly translate the functional modulation of human proteins into safe and effective medicines. We have a pipeline of small molecule clinical and pre-clinical drug candidates for the treatment of a wide range of human diseases including central nervous system disorders, cardiovascular disorders, type I/II diabetes, obesity, and cancer. We have built our product candidate portfolio through internal discovery. We are advancing our product candidates through in-house research and development efforts. In addition, we have strategic collaborations with leading pharmaceutical and biopharmaceutical companies that have contributed to our portfolio of product candidates. We believe the quality and breadth of our product candidate pipeline, platform technology, scientific team and strategic collaborations will enable us to become a fully integrated pharmaceutical company. We are advancing several proprietary product candidates. Our lead product candidate, TTP488, is a novel, orally bioavailable compound that is being developed as a potential treatment for Alzheimer's disease. TTP488 reduces A deposition in the brain and improves performance in the Morris Water Maze relative to controls in a model of AD. We believe the compound has potential benefits beyond purely...